Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janatova

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Cancers|April 17, 2020
Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian CancerKlara Lhotova, Lenka Stolarova, Petra Zemankova, et al.
Oncology Letters|May 8, 2023
Germline multigene panel testing of patients with endometrial cancerJan Kral, Sandra Jelinkova, Petra Zemankova, et al.
Human Mutation|September 12, 2018
BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein bindingLeslie J Burke, Jan Sevcik, Gaetana Gambino, et al.
NPJ Breast Cancer|August 21, 2019
Homologous recombination DNA repair defects in <i>PALB2-</i>associated breast cancersAnqi Li, Felipe C Geyer, Pedro Blecua, et al.
NPJ Breast Cancer|November 23, 2019
Erratum: Publisher Correction: Homologous recombination DNA repair defects in <i>PALB2</i>-associated breast cancersAnqi Li, Felipe C Geyer, Pedro Blecua, et al.
Breast (Edinburgh, Scotland)|March 30, 2024
A deep intronic recurrent CHEK2 variant c.1009-118_1009-87delinsC affects pre-mRNA splicing and contributes to hereditary breast cancer predispositionPetra Zemankova, Marta Cerna, Klara Horackova, et al.
Cancer Medicine|August 16, 2024
A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancerJana Soukupova, Barbora Stastna, Madiha Kanwal, et al.
Cancers|January 30, 2020
The Spectrum of <i>FANCM</i> Protein Truncating Variants in European Breast Cancer CasesGisella Figlioli, Anders Kvist, Emma Tham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer RiskLenka Stolarova, Petra Kleiblova, Petra Zemankova, et al.
Breast (Edinburgh, Scotland)|November 12, 2025
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancerAmandine Billaud, Gisella Figlioli, Clémence Mooser, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Cancers|April 17, 2020
Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian CancerKlara Lhotova, Lenka Stolarova, Petra Zemankova, et al.
Oncology Letters|May 8, 2023
Germline multigene panel testing of patients with endometrial cancerJan Kral, Sandra Jelinkova, Petra Zemankova, et al.
Human Mutation|September 12, 2018
BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein bindingLeslie J Burke, Jan Sevcik, Gaetana Gambino, et al.
NPJ Breast Cancer|August 21, 2019
Homologous recombination DNA repair defects in <i>PALB2-</i>associated breast cancersAnqi Li, Felipe C Geyer, Pedro Blecua, et al.
NPJ Breast Cancer|November 23, 2019
Erratum: Publisher Correction: Homologous recombination DNA repair defects in <i>PALB2</i>-associated breast cancersAnqi Li, Felipe C Geyer, Pedro Blecua, et al.
Breast (Edinburgh, Scotland)|March 30, 2024
A deep intronic recurrent CHEK2 variant c.1009-118_1009-87delinsC affects pre-mRNA splicing and contributes to hereditary breast cancer predispositionPetra Zemankova, Marta Cerna, Klara Horackova, et al.
Cancer Medicine|August 16, 2024
A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancerJana Soukupova, Barbora Stastna, Madiha Kanwal, et al.
Cancers|January 30, 2020
The Spectrum of <i>FANCM</i> Protein Truncating Variants in European Breast Cancer CasesGisella Figlioli, Anders Kvist, Emma Tham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer RiskLenka Stolarova, Petra Kleiblova, Petra Zemankova, et al.
Breast (Edinburgh, Scotland)|November 12, 2025
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancerAmandine Billaud, Gisella Figlioli, Clémence Mooser, et al.
Pageof 11